Litcius/Paper detail

Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus

Xufang Deng, Yafang Chen, Anna M. Mielech, Matthew Hackbart, Kristina R. Kesely, Robert C. Mettelman, Amornrat O’Brien, Mackenzie E. Chapman, Andrew D. Mesecar, Susan C. Baker

2020Journal of Virology27 citationsDOIOpen Access PDF

Abstract

Coronaviruses employ a genetic economy by encoding multifunctional proteins that function in viral replication and also modify the host environment to disarm the innate immune response. The coronavirus papain-like protease 2 (PLP2) domain possesses protease activity, which cleaves the viral replicase polyprotein, and also DUB activity (deconjugating ubiquitin/ubiquitin-like molecules from modified substrates) using identical catalytic residues. To separate the DUB activity from the protease activity, we employed a structure-guided mutagenesis approach and identified residues that are important for ubiquitin binding. We found that mutating the ubiquitin-binding residues results in a PLP2 that has reduced DUB activity but retains protease activity. We engineered a recombinant murine coronavirus to express the DUB mutant and showed that the DUB mutant virus activated an earlier type I interferon response in macrophages and exhibited reduced replication in mice. The results of this study demonstrate that PLP2/DUB is an interferon antagonist and a virulence trait of coronaviruses.

Topics & Concepts

BiologyDeubiquitinating enzymeVirusVirologyUbiquitinViral replicationInterferonCoronavirusProteaseMolecular biologyGeneEnzymeBiochemistryInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)DiseasePathologyMedicineinterferon and immune responsesSARS-CoV-2 and COVID-19 ResearchEndoplasmic Reticulum Stress and Disease